Auxly Cannabis Group Inc (CVE:XLY) (OTCMKTS:CBWTF) shares rolled up Monday after it reported its first-quarter results, with a number of highlights, including subsidiary Dosecann Cannabis Solutions, which pushed forward product research and development, formulation and manufacturing in 1Q. 

Dosecann is developing edible and concentrate products for sale in both medical and recreational markets and owns one of Canada's largest cannabis extraction and manufacturing operations, a 42,000 sq/ft facility in Charlottetown, PEI. Shares were up 1.2% at C$0.83 on Monday afternoon in Canadian trading. 

Chances are that you'd struggle to find a faster-growing industry right now than legal marijuana. With global sales expected to grow by 38% in 2019, and more than double between 2018 and 2022, the cannabis industry has all the makings of a once-in-a-generation investment opportunity.

Then again, choosing what stocks to sink your money into in a nascent industry is never easy. In many instances, the most popular stock in a fast-growing industry isn't the one that winds up being the best long-term investment.

Cronos Group (NASDAQ:CRON), Canada's third-largest pot company by market capitalization, has suddenly turned into a black sheep. In effect, the company's shares have shed 24% of their value since hitting a high-water mark last March following the closure of its $1.8 billion deal with Malboro-maker Altria(NYSE:MO). 

The use of CBD as an ingredient in many treatments and even foods have become an unstoppable trend. Although, various companies were unwilling to sell CBD and related products due to its legal implications, according to Forbes, the financial services company, Square have started to take a slightly different approach. A Square representative spoke to Forbes about how the payment processing service has started to accept payments for specific CBD products.

Aphria (TSX:APHA)(NYSE:APHA) stock tanked after a controversial research report from a hedge fund accused the company of being a shell with a marijuana business on the side. Over the last year, Aphria’s stock has lost 16% compared to the outsized gains of its peers, including industry leader Canopy Growth surging by 63% and Cronos Group gaining a whopping 175%.

This week, lawmakers, cannabis entrepreneurs, investors, and other influential people gathered in Washington D.C. for KCSA’s Congressional Cannabis Day Forum. Speakers included Rep. Earl Blumenauer, CNBC’s Tim Seymour, Rep. David Joyce, Rep. Barbara Lee and Rep. Don Young.

Of all the stories gaining press in 2019, perhaps none will prove more important or impact more American lives and pocketbooks than the ongoing trade war between the United States and China.

American cannabis markets get a lot of attention from investors, and deservedly so.

As far as legal markets go, the various U.S. states constitute the largest in the world, and they'll continue to for years.

After all, the legal marijuana market in California alone is far bigger than the even the vast Canadian market will ever be. Multi-state operators (MSOs) are learning how to build operations and brands across the United States, despite patchwork legalization.

These ingenious pioneers will define the American cannabis market of tomorrow; they'll make millionaires of U.S. cannabis investors, too.

I'm talking market dominance here.

Still… no one can afford to count out the Canadian-licensed producers. They have something that American MSOs don't.

Aurora Cannabis  (TSX:ACB)(NYSE:ACB) may still be in the second spot for top cannabis producer in Canada, but lately analysts and investors haven’t been so sure about the stock. The good news has gone so far up and down that, honestly, I think it’s spooked investors.

So, let’s take a good look at what’s really going on with Aurora right now.

After more than 150 years of brewing beer, Canada’s oldest independent beer company, Moosehead, is preparing to venture into the cannabis beverage market.

Moosehead Breweries Limited and Sproutly Canada Inc. have entered into an agreement to form an exclusive joint venture to develop and produce non-alcoholic cannabis-infused beverages.

The drinks will be manufactured using Sproutly’s proprietary water-soluble cannabinoid technology, Infuz2O , which allows for more efficient bioavailability.